Loading…
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. Its Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $1.4B | $157M | $96M | $104M | 8.8% | 23.2% | 30.3% |
| 2024 | $1.2B | $121M | $74M | $110M | 7.6% | 9.1% | 17.7% |
| 2023 | $1.1B | $107M | $63M | $103M | 8.8% | 11.3% | 35.8% |
| 2022 | $951M | $83M | $46M | $97M | 7.3% | - | - |
| 2021 | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue | - | 951.12 | 1,058.65 | 1,154.60 | 1,422.53 |
| Cost Of Revenue | - | 651.38 | 718.78 | 779.58 | 960.66 |
| Gross Profit | - | 299.74 | 339.88 | 375.02 | 461.87 |
| Operating Expense | - | 231 | 248.92 | 272.33 | 323.26 |
| Operating Income | - | 68.74 | 90.96 | 102.69 | 138.62 |
| EBITDA | - | 83.14 | 106.56 | 120.62 | 157.47 |
| EBIT | - | 69.08 | 92.43 | 107.08 | 141.06 |
| Pretax Income | - | 60.17 | 81.33 | 99.35 | 127.44 |
| Tax Provision | - | 14.15 | 18.81 | 25.76 | 31.54 |
| Net Income | - | 46.02 | 62.52 | 73.60 | 95.91 |
| Net Income Common Stockholders | - | 46.02 | 62.52 | 73.60 | 95.91 |
| Total Expenses | - | 882.38 | 967.70 | 1,051.91 | 1,283.92 |
| Interest Expense | - | 8.91 | 11.11 | 7.73 | 13.61 |
| Interest Income | - | 0.34 | 1.48 | 4.39 | 2.44 |
| Selling General And Administration | - | 216.94 | 234.79 | 258.80 | 306.85 |
| Normalized EBITDA | - | 83.14 | 106.56 | 120.62 | 157.47 |
| Normalized Income | - | 46.02 | 62.52 | 73.60 | 95.91 |
| Market Cap | 1,786.41 | 1,786.41 | 1,786.41 | 1,786.41 | 1,786.41 |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Addus HomeCare Corporationthis co. | ADUS | - | 18.63 | 1.65 | 8.8% | 11.91 |
| Actuate Therapeutics, Inc. Common stock | ACTU | $68M | - | 8.45 | -280.5% | - |
| LENSAR, Inc. | LNSR | $65M | - | -2.48 | 131.7% | -3.17 |
| Pulmonx Corporation | LUNG | $51M | - | 0.92 | -99.8% | -0.71 |
| Accuray Incorporated | ARAY | $50M |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| 0.94 |
| -2.0% |
| -107.66 |
| INmune Bio Inc. | INMB | $35M | - | 1.50 | -195.3% | -0.38 |
| Myomo, Inc. | MYO | $31M | - | 2.68 | -136.6% | -2.33 |
| Tvardi Therapeutics, Inc. | TVRD | $29M | - | 1.37 | -87.0% | 0.07 |
| Tevogen Bio Holdings Inc. | TVGN | $27M | - | -1.52 | 319.1% | -1.64 |
| Peer Median | - | - | 1.15 | -93.4% | -1.64 | |